mizoribine has been researched along with Necrosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujimoto, T; Hamaguchi, Y; Nishino, I; Suzuki, S; Tanaka, T | 1 |
Kobayashi, T; Kuzuya, T; Liu, D; Ma, Y; Miwa, Y; Morozumi, K; Nagasaka, T; Nakao, A; Oikawa, T; Shimano, Y; Takeuchi, O; Uchida, K; Yokoyama, I | 1 |
Arimura, K; Higuchi, I; Hokezu, Y; Inose, M; Izumo, S; Osame, M; Yoshimine, K | 1 |
1 trial(s) available for mizoribine and Necrosis
Article | Year |
---|---|
[A study of clinical symptoms, muscle pathology, therapeutic response, and prognosis of myositis in patients with HTLV-1 associated myelopathy (HAM)].
Topics: Adult; Aged; Anti-Inflammatory Agents; Atrophy; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Muscle, Skeletal; Myositis; Necrosis; Paraparesis, Tropical Spastic; Prednisolone; Prognosis; Ribonucleosides; Treatment Outcome | 1999 |
2 other study(ies) available for mizoribine and Necrosis
Article | Year |
---|---|
What is the third serological marker associated with immune-mediated necrotizing myopathy?
Topics: Aged, 80 and over; ATPases Associated with Diverse Cellular Activities; Autoantibodies; Autoimmunity; Biomarkers; Biopsy; Carrier Proteins; DNA Helicases; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Immunosuppressive Agents; Mitochondria, Muscle; Mitochondrial Proteins; Muscle, Skeletal; Muscular Diseases; Necrosis; Prednisolone; Reproducibility of Results; Ribonucleosides; Serologic Tests; Signal Recognition Particle; Treatment Outcome | 2017 |
Potential value of high-dose mizoribine as rescue therapy for ongoing acute humoral rejection.
Topics: Acute Disease; Animals; Biopsy; Creatinine; Dose-Response Relationship, Drug; Graft Rejection; Hemorrhage; Immunosuppressive Agents; Isoantibodies; Kidney Transplantation; Necrosis; Renal Insufficiency; Ribonucleosides; Salvage Therapy; Survival Analysis; Swine; Time Factors | 2005 |